Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -473.91x is 55% above its 4-year average of -1054.10x, near the high end of its 4-year range (-2930.29x–-119.59x).
Reported quarterly interest coverage; no daily interpolation. Q4 FY2024 (2024-12-31): -119.59x.
INTEREST COVERAGE RATIO
-473.91x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-336.98x
INTEREST COVERAGE RATIO AVG 5Y
-1054.10x
INTEREST COVERAGE RATIO AVG 10Y
-7754.41x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-40.63%
CURRENT VS 5Y AVG
+55.04%
CURRENT VS 10Y AVG
+93.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.68x
median of 480 covered companies
CURRENT VS SECTOR MEDIAN
-8243.49%
vs the sector median at left
Kiora Pharmaceuticals, Inc.
Market Cap
$11.17M
Interest Coverage Ratio
-473.91x
TTM Avg
N/A
3Y Avg
-336.98x
5Y Avg
-1054.10x
Market Cap
$11.19M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.44M
Interest Coverage Ratio
-20.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.54M
Interest Coverage Ratio
26.76x
TTM Avg
26.76x
3Y Avg
26.76x
5Y Avg
26.76x
Market Cap
$10.73M
Interest Coverage Ratio
-309.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. (KPRX) | $11.17M | -473.91x | N/A | -336.98x | -1054.10x |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.19M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.12M | -1265.39x | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.08M | -4.24x | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.44M | -20.24x | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.54M | 26.76x | 26.76x | 26.76x | 26.76x |
| Caring Brands, Inc. (CABR)vs › | $10.73M | -309.66x | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.61M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.68M | -1.99x | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | N/A | N/A | N/A | N/A |
Interest Coverage
-473.9x
Debt/Equity
0.02
Current Ratio
8.97
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | -119.59x |
| 2021-12-31 | -554.37x |
| 2021-06-30 | -1386.87x |
| 2021-03-31 | -2930.29x |
| 2020-12-31 | -279.40x |
| 2019-09-30 | -31663.06x |
| 2019-06-30 | -17312.96x |
| 2019-03-31 | 7672.59x |
| 2018-12-31 | -19448.88x |
| 2018-09-30 | -10453.55x |
| 2018-06-30 | -9204.99x |
| 2018-03-31 | -7825.82x |
| 2017-12-31 | -13771.38x |
| 2017-09-30 | -13618.76x |
| 2017-06-30 | -10907.52x |
| 2017-03-31 | -9635.68x |
| 2016-12-31 | -13458.35x |
| 2015-12-31 | -186.52x |
| 2015-03-31 | -0.58x |
| 2014-12-31 | -2.21x |
| 2014-09-30 | -3.49x |
| 2014-06-30 | -9.70x |
| 2014-03-31 | -27.27x |
| 2013-12-31 | -3.56x |
| 2013-09-30 | -3.90x |
| 2013-06-30 | -5.64x |
| 2013-03-31 | -8.45x |
